Please assess the completion status of the following clinical trial:

Trial Title: Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The patient has histological diagnosis of cancer of the endometrium of any histology or grade.~* The patient should have received no prior treatment for her endometrial cancer.~* The patient has clinically uterine confined disease.~* The patient is a candidate for minimal invasive surgery, with sentinel lymph node assessment with IC-GREEN planned as part of standard of care.~* The patient has an Eastern Cooperative Group (ECOG) performance status of 0-2.~* If age less than or equal to 55 years, the patient has a negative pregnancy test within 72 hours before administration of Lymphoseek, has been surgically sterilized, or has been postmenopausal for at least 1 year.~* The patient has provided written informed consent.~* The patient is at least 18 years of age at the time of consent~Exclusion Criteria:~* The patient has clinical or radiological evidence of metastatic disease.~* The patient has a history of a prior loop electrosurgical excision procedure (LEEP) or cone procedure performed on her cervix.~* The patient has participated in another investigational drug study within 30 days of scheduled surgery.~* The patient has an iodine allergy.~* The patient is pregnant or lactating.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lymphoseek/SPECT-CT/Indocyanine (Type: EXPERIMENTAL): The subject will receive f 0.5 mL each Lymphoseek into the uterine cervix prior to surgery and subsequent SPECT/CT imaging preoperatively. Intraoperatively, following anesthesia induction, Indocyanine Green (0.5 mL) will be injected into the uterine cervix. Using near-infrared imaging, efferent lymphatic vessels and lymph nodes will be visualized and confirmed by detected radioactivity using a laparoscopic gamma counter. The preoperatively obtained SPECT/CT images will help guide the surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).